Chemoinformaics analysis of (2R,3R)-alpinone
Molecular Weight | 286.283 | nRot | 2 |
Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
Exact Molecular Weight | 286.084 | nRing | 3 |
Solubility: LogS | -2.784 | nHRing | 1 |
Solubility: LogP | 2.097 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
nHA | 5 | APOL | 40.0651 |
nHD | 2 | BPOL | 18.3849 |
QED | 0.884 |
Synth | 3.171 |
Natural Product Likeliness | 1.106 |
NR-PPAR-gamma | 0.811 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.075 |
HIA | 0.007 |
CACO-2 | -4.968 |
MDCK | 0.00000774 |
BBB | 0.255 |
PPB | 0.91314 |
VDSS | 0.951 |
FU | 0.0578198 |
CYP1A2-inh | 0.132 |
CYP1A2-sub | 0.356 |
CYP2c19-inh | 0.173 |
CYP2c19-sub | 0.86 |
CYP2c9-inh | 0.533 |
CYP2c9-sub | 0.941 |
CYP2d6-inh | 0.209 |
CYP2d6-sub | 0.701 |
CYP3a4-inh | 0.124 |
CYP3a4-sub | 0.607 |
CL | 4.372 |
T12 | 0.391 |
hERG | 0.072 |
Ames | 0.073 |
ROA | 0.175 |
SkinSen | 0.477 |
Carcinogencity | 0.03 |
EI | 0.466 |
Respiratory | 0.367 |
NR-Aromatase | 0.213 |
Antiviral | Yes |
Prediction | 0.886888 |